Cincinnati Financial Corporation (CINF)

Intra-Cellular Therapies Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Premiums & Annuity Revenue	9,486	8,889	7,958	7,225	6,478	5,980
Total Interest & Dividend Income	1,103	1,025	894	781	714	670
Gain (Loss) on Sale of Investments	1,048	1,391	1,127	-1,467	2,409	865
Other Revenue	35	32	34	24	25	21
Total Revenue	11,672	11,337	10,013	6,563	9,626	7,536
Revenue Growth (YoY)	9.64%	13.22%	52.57%	-31.82%	27.73%	-4.90%
Policy Benefits	6,542	5,743	5,279	5,025	3,914	4,144
Policy Acquisition & Underwriting Costs	2,697	2,558	2,292	2,072	1,862	1,734
Other Operating Expenses	134	125	112	107	99	105
Total Operating Expenses	9,373	8,426	7,683	7,204	5,875	5,983
Operating Income	2,299	2,911	2,330	-641	3,751	1,553
Interest Expense	-53	-53	-54	-53	-53	-54
Pretax Income	2,246	2,858	2,276	-694	3,698	1,499
Income Tax Expense	426	566	433	-207	730	283
Net Income	1,820	2,292	1,843	-487	2,968	1,216
Net Income to Common	1,820	2,292	1,843	-487	2,968	1,216
Net Income Growth	-15.39%	24.36%	-	-	144.08%	-39.11%
Shares Outstanding (Basic)	156	156	157	159	161	161
Shares Outstanding (Diluted)	158	158	158	159	163	162
Shares Change (YoY)	0.03%	-0.19%	-0.44%	-2.40%	0.18%	-1.64%
EPS (Basic)	11.64	14.65	11.74	-3.07	18.43	7.54
EPS (Diluted)	11.53	14.53	11.66	-3.07	18.24	7.49
EPS Growth	-15.42%	24.61%	-	-	143.52%	-38.10%
Free Cash Flow	2,588	2,627	2,034	2,037	1,966	1,471
Free Cash Flow Per Share	16.39	16.65	12.87	12.83	12.08	9.06
Dividend Per Share	3.360	3.240	3.000	2.760	2.520	2.400
Dividend Growth	7.69%	8.00%	8.70%	9.52%	5.00%	7.14%
Operating Margin	19.70%	25.68%	23.27%	-9.77%	38.97%	20.61%
Profit Margin	15.59%	20.22%	18.41%	-7.42%	30.83%	16.14%
Free Cash Flow Margin	22.17%	23.17%	20.31%	31.04%	20.42%	19.52%
EBITDA	2,446	3,041	2,442	-514	3,869	1,662
EBITDA Margin	20.96%	26.82%	24.39%	-7.83%	40.19%	22.05%
D&A For EBITDA	147	130	112	127	118	109
EBIT	2,299	2,911	2,330	-641	3,751	1,553
EBIT Margin	19.70%	25.68%	23.27%	-9.77%	38.97%	20.61%
Effective Tax Rate	18.97%	19.80%	19.02%	-	19.74%	18.88%
Revenue as Reported	11,672	11,337	10,013	6,563	9,626	7,536

Updated Jul 28, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q